These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2695331)

  • 21. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF; Goa KL
    Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fluoroquinolones as treatment for infections caused by gram-positive bacteria.
    Cruciani M; Bassetti D
    J Antimicrob Chemother; 1994 Mar; 33(3):403-17. PubMed ID: 8040107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis.
    Gentry LO; Rodriguez GG
    Antimicrob Agents Chemother; 1990 Jan; 34(1):40-3. PubMed ID: 2183710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quinolones and osteomyelitis: state-of-the-art.
    Lew DP; Waldvogel FA
    Drugs; 1995; 49 Suppl 2():100-11. PubMed ID: 8549277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group.
    J Antimicrob Chemother; 1988 Aug; 22(2):221-8. PubMed ID: 3053554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Lesse AJ; Freer C; Salata RA; Francis JB; Scheld WM
    Am J Med; 1987 Apr; 82(4A):247-53. PubMed ID: 3555043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oral antibiotic therapy in the adult bacterial osteomyelitis: results after two years of follow-up].
    Javaloyas de Morlius M; Monreal Portella M
    Med Clin (Barc); 1999 Oct; 113(13):488-9. PubMed ID: 10604172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy, safety, and potential economic benefits of oral ciprofloxacin in the treatment of infections.
    Sanders WE
    Rev Infect Dis; 1988; 10(3):528-43. PubMed ID: 3293158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic osteomyelitis caused by multi-resistant Gram-negative bacteria: evaluation of treatment with newer quinolones after prolonged follow-up.
    Galanakis N; Giamarellou H; Moussas T; Dounis E
    J Antimicrob Chemother; 1997 Feb; 39(2):241-6. PubMed ID: 9069546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
    Scully BE; Neu HC
    Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis.
    Bosso JA; Black PG; Matsen JM
    Am J Med; 1987 Apr; 82(4A):180-4. PubMed ID: 3555033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative chemotherapeutic activity of new fluorinated 4-quinolones and standard agents against a variety of bacteria in a mouse infection model.
    Sesnie JC; Fritsch PW; Griffin TJ; Heifetz CL; Leopold ET; Malta TE; Shapiro MA; Vincent PW
    J Antimicrob Chemother; 1989 May; 23(5):729-36. PubMed ID: 2759922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis.
    Greenberg RN; Tice AD; Marsh PK; Craven PC; Reilly PM; Bollinger M; Weinandt WJ
    Am J Med; 1987 Apr; 82(4A):266-9. PubMed ID: 3555046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of animal models in evaluation of the quinolones.
    Sande MA; Brooks-Fournier RA; Gerberding JL
    Rev Infect Dis; 1988; 10 Suppl 1():S113-6. PubMed ID: 3279487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral ciprofloxacin in refractory gram-negative bacillary infections.
    Bryant RE; Hartstein AI
    Int J Clin Pharmacol Res; 1987; 7(3):187-94. PubMed ID: 3596862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term use of quinolones and their safety.
    Ball P
    Rev Infect Dis; 1989; 11 Suppl 5():S1365-70. PubMed ID: 2672258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
    Thys JP; Jacobs F; Byl B
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):304-15. PubMed ID: 1864291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe skull base osteomyelitis caused by Pseudomonas aeruginosa with successful outcome after prolonged outpatient therapy with continuous infusion of ceftazidime and oral ciprofloxacin: a case report.
    Conde-Díaz C; Llenas-García J; Parra Grande M; Terol Esclapez G; Masiá M; Gutiérrez F
    J Med Case Rep; 2017 Feb; 11(1):48. PubMed ID: 28219414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous ciprofloxacin therapy in severe infections.
    Gudiol F; Cabellos C; Pallares R; Linares J; Ariza J
    Am J Med; 1989 Nov; 87(5A):221S-224S. PubMed ID: 2589364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The fluoroquinolones.
    Walker RC
    Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.